Janssen fully explores new pathways to develop innovative health solutions. Along with a number of external experts, the company developed an educational online game for children between 8 and 12 years of age with ADHD (Attention Deficit Hyperactivity Disorder). Plan-it Commander is more than just a fun and challenging game. This ‘serious game’ was developed with the ambition of demonstrably improving the quality of life of young ADHD patients and their families. 

heal-seaker-4.png

The Janssen team, which launched the original idea at an Entrepreneurial Boot Camp, worked together with the Centrum ZitStil, the association of parents of children with ADHD, game developer RANJ and mental health expert organization Yulius in the Netherlands. This was a cooperative enterprise fitting in with the open innovation policy aimed at sharing knowledge and know-how with others.

After the market launch and positive results, Plan-it won the award for the ‘Best Health Game 2013’ at the Fun and Serious Game Festival in Bilbao, one of the most important festivals in Europe for this still emerging industry branch. This was important recognition of the quality of the work supplied.

heal-seaker-5.png.jpg

Plan-it Commander was developed with the ambition of demonstrably improving the quality of life of young ADHD patients and their families.

Durabilité
Économique

Janssen believes that strong corporate results, correct policies and focused activities pave the way towards economic sustainability. 

Janssen must constantly reinvent itself in order to cope with the structural and economic changes that affect its environment. This is why Janssen is committed to build partnerships within an open innovation model, and to the continuous alignment of its cost-competitiveness by only developing medicines with a high therapeutic added value. 

For Janssen this means specifically: being focused and a leader in research & development, and being efficient and progressive in terms of production with the aim of bringing new therapeutic solutions to patients quicker and at less expense, and implementing a growth strategy to ensure our continued investment in all these areas.